CorMedix Inc (NASDAQ: CRMD) kicked off on Friday, down -0.55% from the previous trading day, before settling in for the closing price of $9.15. Over the past 52 weeks, CRMD has traded in a range of $3.61-$13.85.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -40.30% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 333.33%. With a float of $59.59 million, this company’s outstanding shares have now reached $64.41 million.
In an organization with 65 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 92.66%, operating margin of -51.43%, and the pretax margin is -44.45%.
CorMedix Inc (CRMD) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of CorMedix Inc is 8.59%, while institutional ownership is 35.15%. The most recent insider transaction that took place on Oct 31 ’24, was worth 14,985. In this transaction EVP, Chief Commercial Officer of this company bought 1,500 shares at a rate of $9.99, taking the stock ownership to the 52,011 shares. Before that another transaction happened on Nov 14 ’24, when Company’s EVP sold 140,027 for $11.18, making the entire transaction worth $1,565,670. This insider now owns 45,397 shares in total.
CorMedix Inc (CRMD) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 333.33% per share during the next fiscal year.
CorMedix Inc (NASDAQ: CRMD) Trading Performance Indicators
Take a look at CorMedix Inc’s (CRMD) current performance indicators. Last quarter, stock had a quick ratio of 3.16. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.65.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.33, a number that is poised to hit 0.26 in the next quarter and is forecasted to reach 1.41 in one year’s time.
Technical Analysis of CorMedix Inc (CRMD)
Let’s dig in a bit further. During the last 5-days, its volume was 1.34 million. That was inferior than the volume of 1.45 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 93.57%. Additionally, its Average True Range was 0.57.
During the past 100 days, CorMedix Inc’s (CRMD) raw stochastic average was set at 46.73%, which indicates a significant decrease from 97.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 50.46% in the past 14 days, which was lower than the 96.59% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.95, while its 200-day Moving Average is $8.56. However, in the short run, CorMedix Inc’s stock first resistance to watch stands at $9.22. Second resistance stands at $9.34. The third major resistance level sits at $9.48. If the price goes on to break the first support level at $8.96, it is likely to go to the next support level at $8.82. The third support level lies at $8.70 if the price breaches the second support level.
CorMedix Inc (NASDAQ: CRMD) Key Stats
The company with the Market Capitalisation of 593.15 million has total of 65,182K Shares Outstanding. Its annual sales at the moment are 43,470 K in contrast with the sum of -17,930 K annual income. Company’s last quarter sales were recorded 31,210 K and last quarter income was 13,460 K.
